West Pharmaceutical Services, Inc. (WST) Tops Q1 EPS by 16c; Raises FY Guidance
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $327.95 +1.35%
Revenue Growth %: +9.5%
Financial Fact:
Interest expense: 2.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +9.5%
Financial Fact:
Interest expense: 2.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.81, $0.16 better than the analyst estimate of $0.65. Revenue for the quarter came in at $316.3 million versus the consensus estimate of $308.2 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
